» Articles » PMID: 17409401

Aurora a and B Overexpression and Centrosome Amplification in Early Estrogen-induced Tumor Foci in the Syrian Hamster Kidney: Implications for Chromosomal Instability, Aneuploidy, and Neoplasia

Overview
Journal Cancer Res
Specialty Oncology
Date 2007 Apr 6
PMID 17409401
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Estrogen-induced Syrian hamster tumors in the kidney represent a useful model to gain insight into the role of estrogens in oncogenic processes. We provided evidence that early tumor foci in the kidney arise from interstitial ectopic uterine-like germinal stem cells, and that early tumor foci and well-established tumors are highly aneuploid (92-94%). The molecular mechanisms whereby estrogens mediate this process are unclear. Here, we report that estrogen treatment induced significant increases in Aurora A protein expression (8.7-fold), activity (2.6-fold), mRNA (6.0-fold), and Aurora B protein expression (4.6-fold) in tumors, compared with age-matched cholesterol-treated kidneys. Immunohistochemistry revealed that this increase in Aurora A and B protein expression was essentially confined to cells within early and large tumor foci at 3.5 and 6 months of estrogen treatment, respectively. Upon estrogen withdrawal or coadministration of tamoxifen for 10 days, a 78% to 79% and 81% to 64% reduction in Aurora A and B expression, respectively, were observed in primary tumors compared with tumors continuously exposed to estrogens. These data indicate that overexpressed Aurora A and B in these tumors are under estrogen control via estrogen receptor alpha. Aurora A coenriched with the centrosome fraction isolated from tumors in the kidney. Centrosome amplification (number and area/cell) was detected in early tumor foci and large tumors but not in adjacent uninvolved or age-matched control kidneys. Taken together, these data indicate that persistent overexpression of Aurora A and B is under estrogen control, and is coincident with centrosome amplification, chromosomal instability, and aneuploidy, and represent an important mechanism driving tumorigenesis.

Citing Articles

Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours.

Johnson M, Wang J, Falchook G, Greenlees C, Jones S, Strickland D Br J Cancer. 2023; 128(10):1906-1915.

PMID: 36871042 PMC: 10147685. DOI: 10.1038/s41416-023-02185-2.


Estrogens-Origin of Centrosome Defects in Human Cancer?.

Buhler M, Stolz A Cells. 2022; 11(3).

PMID: 35159242 PMC: 8833882. DOI: 10.3390/cells11030432.


Regulation of steroid hormone receptors and coregulators during the cell cycle highlights potential novel function in addition to roles as transcription factors.

Zheng Y, Murphy L Nucl Recept Signal. 2016; 14:e001.

PMID: 26778927 PMC: 4714463. DOI: 10.1621/nrs.14001.


Replication stress in Mammalian cells and its consequences for mitosis.

Gelot C, Magdalou I, Lopez B Genes (Basel). 2015; 6(2):267-98.

PMID: 26010955 PMC: 4488665. DOI: 10.3390/genes6020267.


Inhibitor of Aurora Kinase B Induces Differentially Cell Death and Polyploidy via DNA Damage Response Pathways in Neurological Malignancy: Shedding New Light on the Challenge of Resistance to AZD1152-HQPA.

Zekri A, Ghaffari S, Yaghmaie M, Estiar M, Alimoghaddam K, Modarressi M Mol Neurobiol. 2015; 53(3):1808-1823.

PMID: 25752998 DOI: 10.1007/s12035-015-9139-9.